Episode Details
Back to Episodes
FDA Approves First Alzheimer’s Drug in Years | Chicago News
Published 1 day, 7 hours ago
Description
FDA just approved Lecanemab, the first drug in years to slow Alzheimer’s progression—targeting brain plaques to protect cognitive function. Not a cure, but a major leap forward with real-world benefits for early-stage patients, though it comes with monitoring requirements and hefty costs.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/639e0d91cbfbf34f